ATGE Adtalem Global Education Inc.

Adtalem Global Education Appoints Dr. Charles DeShazer to Its Board of Directors

Adtalem Global Education (NYSE: ATGE), a leading workforce solutions provider, today announced the appointment of Dr. Charles DeShazer as an independent member of Adtalem’s board of directors.

“We are thrilled to welcome Charles to the Adtalem board. Charles’ impressive leadership experience across the healthcare services ecosystem, coupled with his background as a board-certified M.D. in internal medicine, will enable us to leverage his expertise in executing our strategy of becoming a leading provider of workforce solutions to the rapidly-evolving healthcare industry,” stated Lisa Wardell, chairman and CEO of Adtalem Global Education. “As technology accelerates changes in the way patients seek and receive care, Charles’ unique perspectives will greatly help us in further enhancing our programs and offerings to meet the evolving needs of our healthcare employer partners and addressing the critical talent shortages facing the sector.”

With this appointment, the Adtalem board of directors will be composed of 10 directors, nine of whom are independent. The board’s gender and ethnic composition includes four women and five persons of color, demonstrating Adtalem’s ongoing commitment to board diversity as a business imperative.

DeShazer currently serves as the director of clinical products at Google where he helps lead the design and implementation of an intelligent suite of tools that help healthcare providers deliver better patient care. Prior to this role, DeShazer served as the senior vice president and chief medical officer (CMO) of Highmark, Inc., one of the largest insurance organizations in the U.S from 2017 to 2021. In this role, he oversaw the company’s clinical strategy, overall medical leadership and provided oversight of Highmark, Inc.'s strategic direction and processes related to health care quality, efficiency and cost improvement. Additionally, as the CMO for the primary division of Highmark Health, DeShazer also interacted regularly with the smaller health system division, Allegheny Health Network, as well as Penn State Health, a large academic health system governed jointly by Penn State University and Highmark Health through a significant minority ownership investment. Prior to Highmark, DeShazer has served for more than 25 years in various executive leadership roles overseeing medical informatics, quality improvement, medical management and care delivery redesign across several organizations, including: a leading U.S. healthcare system, Baycare; health insurance companies, Humana and Highmark; and at the leading integrated health organization, Kaiser Permanente.

About Adtalem Global Education

The purpose of Adtalem Global Education is to empower students to achieve their goals, find success, and make inspiring contributions to our global community. Adtalem Global Education Inc. (NYSE: ATGE; member S&P MidCap 400 Index) is a leading global education provider and the parent organization of American University of the Caribbean School of Medicine, Association of Certified Anti-Money Laundering Specialists, Becker Professional Education, Chamberlain University, EduPristine, Ross University School of Medicine and Ross University School of Veterinary Medicine. For more information, please visit and follow on Twitter () and .

EN
31/03/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Adtalem Global Education Inc.

Moody's Ratings assigns Ba2 rating to Adtalem's proposed senior secure...

Moody's Ratings (Moody's) has assigned a Ba2 rating to Adtalem Global Education Inc.'s (Adtalem) proposed $510 million senior secured term loan B due 2033. All other ratings, including the company's Ba2 corporate family rating (CFR), Ba2-PD probability of default rating, Ba2 senior secured revolving...

Adtalem Global Education Inc.: The newly authorized and expanded $750 ...

New share expansion is credit negative but has no immediate impact on ratings

Moody's Ratings says Adtalem's newly authorized and expanded $750 mill...

Moody's Ratings (Moody's) said that Adtalem Global Education Inc's. (Adtalem) announcement that its board of directors authorized a new $750 million share repurchase program to be executed over the next 36 months is a negative credit development but does not have an immediate effect on the company's...

Adtalem Global Education Inc.: Consistent track record of strategy exe...

Our credit view of this issuer reflects its strong credit metrics and its balanced financial strategies and very good liquidity, against its legal and reputational risks.

Moody's Ratings upgrades Adtalem's CFR and senior secured ratings to B...

Moody's Ratings (Moody's) upgraded Adtalem Global Education Inc.'s (Adtalem) corporate family rating (CFR) to Ba2 from Ba3 and its probability of default rating (PDR) to Ba2-PD from Ba3-PD. At the same time, we upgraded the company's senior secured first lien bank credit facility rating (revolver an...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch